远程医疗公司Hims & Hers Health Inc.(HIMS)周四盘后股价大涨11.9%,引发市场广泛关注。公司刚刚公布的前三季度财报数据堪称优异,成为推动股价飙升的主因。
在运营方面,Hims & Hers前三季度净利润达到1亿美元,较去年同期亏损2,479.1万美元实现扭亏为盈。营收同比大增58.9%至9.954亿美元,主要来自在线销售渠道的处方药和非处方产品。财报显示,公司高达80.7%的毛利率为其获取更多利润奠定了坚实基础。
出色的业绩凸显了Hims & Hers在远程医疗行业中的强劲竞争力。公司不断致力于为患者提供更便捷的诊疗渠道,受到用户的广泛欢迎。良好的财务状况和强劲增长潜力让投资者看好Hims & Hers未来的发展前景,从而在盘后交易中积极买入该股,推动股价大涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.